Evidence map›Paper›PMID 37151225›Full record

ArticleBrain communications2023

Eigenvector centrality dynamics are related to Alzheimer's disease pathological changes in non-demented individuals.

Luigi Lorenzini, Silvia Ingala, Lyduine E Collij, Viktor Wottschel, Sven Haller, Kaj Blennow, Giovanni Frisoni, Gaël Chételat, Pierre Payoux, Pablo Lage-Martinez and 11 more

Open access · goldAbstract read
In one paragraph

Article in Brain communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Dynamic functional connectivity is modulated by the amount of p-Tau231 in blood in cognitively intact participants.Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2025
    Article
  6. Article
  7. A Shift Toward Supercritical Brain Dynamics Predicts Alzheimer's Disease Progression.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 15 institutions in 11 countries.

Luigi LorenziniDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Centre, Vrije Universiteit, Amsterdam Neuroscience, Amsterdam 1081 HV, The Netherlands.ORCID https://orcid.org/0000-0002-9756-881X
Silvia IngalaDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Centre, Vrije Universiteit, Amsterdam Neuroscience, Amsterdam 1081 HV, The Netherlands.
Lyduine E CollijDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Centre, Vrije Universiteit, Amsterdam Neuroscience, Amsterdam 1081 HV, The Netherlands.ORCID https://orcid.org/0000-0001-6263-1762
Viktor WottschelDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Centre, Vrije Universiteit, Amsterdam Neuroscience, Amsterdam 1081 HV, The Netherlands.
Sven HallerCIMC-Centre d'Imagerie Médicale de Cornavin, 1201Genève, Switzerland.
Kaj BlennowDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal 431 41, Sweden.
Giovanni FrisoniLaboratory Alzheimer's Neuroimaging & Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia 25125, Italy.
Gaël ChételatUniversité de Normandie, Unicaen, Inserm, U1237, PhIND 'Physiopathology and Imaging of Neurological Disorders', Institut Blood-and-Brain @ Caen-Normandie, Cyceron, 14000 Caen, France.
Pierre PayouxDepartment of Nuclear Medicine, Toulouse University Hospital, Toulouse 31300, France.
Pablo Lage-MartinezCentro de Investigación y Terapias Avanzadas, Neurología, CITA-Alzheimer Foundation, San Sebastián 20009, Spain.
Michael EwersGerman Center for Neurodegenerative Diseases (DZNE), Munich 81377, Germany.ORCID https://orcid.org/0000-0001-5231-1714
Adam WaldmanCentre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK.
Joanna WardlawCentre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK.ORCID https://orcid.org/0000-0002-9812-6642
Craig RitchieCentre for Dementia Prevention, The University of Edinburgh, Scotland, UK.
Juan Domingo GispertBarcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.ORCID https://orcid.org/0000-0001-5564-2025
Henk J M M MutsaertsDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Centre, Vrije Universiteit, Amsterdam Neuroscience, Amsterdam 1081 HV, The Netherlands.
Pieter Jelle VisserDepartment of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.
Philip ScheltensDepartment of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.
Betty TijmsDepartment of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.ORCID https://orcid.org/0000-0002-2612-1797
Frederik BarkhofDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Centre, Vrije Universiteit, Amsterdam Neuroscience, Amsterdam 1081 HV, The Netherlands.
Alle Meije WinkDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Centre, Vrije Universiteit, Amsterdam Neuroscience, Amsterdam 1081 HV, The Netherlands.ORCID https://orcid.org/0000-0002-8197-0118
Amsterdam Neuroscience · NLCopenhagen University Hospital · DKFundacion CITA Alzheimer · ESGerman Center for Neurodegenerative Diseases · DEGhent University · BEImperial College London · GBInserm · FRKarolinska Institutet · SESahlgrenska University Hospital · SEUK Dementia Research Institute · GBUniversitat Pompeu Fabra · ESUniversité Toulouse III - Paul Sabatier · FRUniversity of Edinburgh · GBUniversity of Geneva · CHUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyloid-β accumulation starts in highly connected brain regions and is associated with functional connectivity alterations in the early stages of Alzheimer's disease. This regional vulnerability is related to the high neuronal activity and strong fluctuations typical of these regions. Recently, dynamic functional connectivity was introduced to investigate changes in functional network organization over time. High dynamic functional connectivity variations indicate increased regional flexibility to participate in multiple subnetworks, promoting functional integration. Currently, only a limited number of studies have explored the temporal dynamics of functional connectivity in the pre-dementia stages of Alzheimer's disease. We study the associations between abnormal cerebrospinal fluid amyloid and both static and dynamic properties of functional hubs, using eigenvector centrality, and their relationship with cognitive performance, in 701 non-demented participants from the European Prevention of Alzheimer's Dementia cohort. Voxel-wise eigenvector centrality was computed for the whole functional magnetic resonance imaging time series (static), and within a sliding window (dynamic). Differences in static eigenvector centrality between amyloid positive (A+) and negative (A-) participants and amyloid-tau groups were found in a general linear model. Dynamic eigenvector centrality standard deviation and range were compared between groups within clusters of significant static eigenvector centrality differences, and within 10 canonical resting-state networks. The effect of the interaction between amyloid status and cognitive performance on dynamic eigenvector centrality variability was also evaluated with linear models. Models were corrected for age, sex, and education level. Lower static centrality was found in A+ participants in posterior brain areas including a parietal and an occipital cluster; higher static centrality was found in a medio-frontal cluster. Lower eigenvector centrality variability (standard deviation) occurred in A+ participants in the frontal cluster. The default mode network and the dorsal visual networks of A+ participants had lower dynamic eigenvector centrality variability. Centrality variability in the default mode network and dorsal visual networks were associated with cognitive performance in the A- and A+ groups, with lower variability being observed in A+ participants with good cognitive scores. Our results support the role and timing of eigenvector centrality alterations in very early stages of Alzheimer's disease and show that centrality variability over time adds relevant information on the dynamic patterns that cause static eigenvector centrality alterations. We propose that dynamic eigenvector centrality is an early biomarker of the interplay between early Alzheimer's disease pathology and cognitive decline.

Indexed as

amyloideigenvector centralityfunctional connectivitypreclinical Alzheimer’s disease

Identifiers

PMID37151225
PMCPMC10156145
OpenAlexW4361225649

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.